Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer

  Free Subscription


30.07.2018

1 Am J Clin Exp Urol
1 Biosci Rep
1 Cancer Chemother Pharmacol
1 Cancer Control
1 Cent European J Urol
1 Curr Urol Rep
1 Drug Deliv
1 Epidemiology
1 Eur J Surg Oncol
3 Eur Urol
2 Eur Urol Focus
1 EXCLI J
1 Gene
2 Int Braz J Urol
1 Int J Environ Res Public Health
1 Int J Urol
1 J Cancer
1 Medicine (Baltimore)
1 Mol Genet Genomic Med
1 Oncoscience
1 PLoS One
1 Proc Natl Acad Sci U S A
1 Ther Adv Urol
3 Urol Oncol
1 Urologe A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Exp Urol

  1. RAMAKRISHNAN S, Huss W, Foster B, Ohm J, et al
    Transcriptional changes associated with in vivo growth of muscle-invasive bladder cancer cell lines in nude mice.
    Am J Clin Exp Urol. 2018;6:138-148.
    PubMed     Text format     Abstract available


    Biosci Rep

  2. LI J, Li Y, Meng F, Fu L, et al
    Knockdown of long non-coding RNA LINC00511 suppresses proliferation and promotes apoptosis of bladder cancer cells via suppressing Wnt/beta-catenin signaling pathway.
    Biosci Rep. 2018 Jul 24. pii: BSR20171701. doi: 10.1042/BSR20171701.
    PubMed     Text format     Abstract available


    Cancer Chemother Pharmacol

  3. NI F, Yan CY, Zhou S, Hui PY, et al
    Repression of GRIM19 expression potentiates cisplatin chemoresistance in advanced bladder cancer cells via disrupting ubiquitination-mediated Bcl-xL degradation.
    Cancer Chemother Pharmacol. 2018 Jul 21. pii: 10.1007/s00280-018-3651.
    PubMed     Text format     Abstract available


    Cancer Control

  4. LAKKIS NA, Adib SM, Hamadeh GN, El-Jarrah RT, et al
    Bladder Cancer in Lebanon: Incidence and Comparison to Regional and Western Countries.
    Cancer Control. 2018;25:1073274818789359.
    PubMed     Text format     Abstract available


    Cent European J Urol

  5. KUTWIN P, Konecki T, Borkowska EM, Traczyk-Borszynska M, et al
    Urine miRNA as a potential biomarker for bladder cancer detection - a meta-analysis.
    Cent European J Urol. 2018;71:177-185.
    PubMed     Text format     Abstract available


    Curr Urol Rep

  6. DASON S, Goh AC
    Updates on Robotic Intracorporeal Urinary Diversions.
    Curr Urol Rep. 2018;19:28.
    PubMed     Text format     Abstract available


    Drug Deliv

  7. KIM SY, Kwon WA, Shin SP, Seo HK, et al
    Electrostatic interaction of tumor-targeting adenoviruses with aminoclay acquires enhanced infectivity to tumor cells inside the bladder and has better cytotoxic activity.
    Drug Deliv. 2018;25:49-58.
    PubMed     Text format     Abstract available


    Epidemiology

  8. RICHARDSON DB, Cardis E, Daniels RD, Gillies M, et al
    Site-specific Solid Cancer Mortality After Exposure to Ionizing Radiation: A Cohort Study of Workers (INWORKS).
    Epidemiology. 2018;29:31-40.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  9. GIULIANELLI R, Gentile BC, Mirabile G, Albanesi L, et al
    Narrow Band Imaging reduces persistence of cancer in patients with pT1 high grade bladder cancer.
    Eur J Surg Oncol. 2018 Jun 18. pii: S0748-7983(18)31125.
    PubMed     Text format     Abstract available


    Eur Urol

  10. KRANTZ D, Hartana CA, Winerdal ME, Johansson M, et al
    Neoadjuvant Chemotherapy Reinforces Antitumour T cell Response in Urothelial Urinary Bladder Cancer.
    Eur Urol. 2018 Jul 16. pii: S0302-2838(18)30476.
    PubMed     Text format     Abstract available

  11. PANEBIANCO V, Barentsz J, Narumi Y, Catto J, et al
    Reply to Andrea Necchi, Antonella Messina, and Alberto Briganti's Letter to the Editor re: Valeria Panebianco, Yoshifumi Narumi, Ersan Altun, et al. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging
    Eur Urol. 2018 Jul 17. pii: S0302-2838(18)30457.
    PubMed     Text format    

  12. HOVELSON DH, Udager AM, McDaniel AS, Grivas P, et al
    Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
    Eur Urol. 2018 Jul 19. pii: S0302-2838(18)30475.
    PubMed     Text format     Abstract available


    Eur Urol Focus

  13. RABY SEM, Choudhury A
    Radiotherapy for High-grade T1 Bladder Cancer.
    Eur Urol Focus. 2018 Jul 19. pii: S2405-4569(18)30183.
    PubMed     Text format     Abstract available

  14. LIEM EIML, Freund JE, Savci-Heijink CD, de la Rosette JJMCH, et al
    Validation of Confocal Laser Endomicroscopy Features of Bladder Cancer: The Next Step Towards Real-time Histologic Grading.
    Eur Urol Focus. 2018 Jul 19. pii: S2405-4569(18)30178.
    PubMed     Text format     Abstract available


    EXCLI J

  15. SHIN SS, Ko MC, Park YJ, Hwang B, et al
    Hydrangenol inhibits the proliferation, migration, and invasion of EJ bladder cancer cells via p21(WAF1)-mediated G1-phase cell cycle arrest, p38 MAPK activation, and reduction in Sp-1-induced MMP-9 expression.
    EXCLI J. 2018;17:531-543.
    PubMed     Text format     Abstract available


    Gene

  16. LI M, Liu Y, Zhang X, Liu J, et al
    Transcriptomic analysis of high-throughput sequencing about circRNA, lncRNA and mRNA in bladder cancer.
    Gene. 2018 Jul 16. pii: S0378-1119(18)30815-1. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


    Int Braz J Urol

  17. YI Y, Wu A, Cameron AP
    Nephrogenic adenoma of the bladder: a single institution experience assessing clinical factors.
    Int Braz J Urol. 2018;44:506-511.
    PubMed     Text format     Abstract available

  18. POCH MA, Patel S, Garcia-Getting R
    The present and future enhanced recovery after surgery for bladder cancer.
    Int Braz J Urol. 2018;44.
    PubMed     Text format    


    Int J Environ Res Public Health

  19. CARTA A, Pavanello S, Mastrangelo G, Fedeli U, et al
    Impact of Occupational Exposures and Genetic Polymorphisms on Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer.
    Int J Environ Res Public Health. 2018;15.
    PubMed     Text format     Abstract available


    Int J Urol

  20. OHTAKA M, Kawahara T, Ishiguro Y, Sharma M, et al
    Expression of receptor activator of nuclear factor kappa B ligand in bladder cancer.
    Int J Urol. 2018 Jul 24. doi: 10.1111/iju.13756.
    PubMed     Text format    


    J Cancer

  21. ZHANG G, Zhang Y, Dong D, Wang F, et al
    MCT1 regulates aggressive and metabolic phenotypes in bladder cancer.
    J Cancer. 2018;9:2492-2501.
    PubMed     Text format     Abstract available


    Medicine (Baltimore)

  22. HU J, Chen JB, Cui Y, Zhu YW, et al
    Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: A systematic review and meta-analysis.
    Medicine (Baltimore). 2018;97:e11596.
    PubMed     Text format     Abstract available


    Mol Genet Genomic Med

  23. HADAMI K, Dakka N, Bensaid M, El Ahanidi H, et al
    Evaluation of glutathione S-transferase pi 1 expression and gene promoter methylation in Moroccan patients with urothelial bladder cancer.
    Mol Genet Genomic Med. 2018 Jul 24. doi: 10.1002.
    PubMed     Text format     Abstract available


    Oncoscience

  24. FANTINI D, Meeks JJ
    The BBN model: a mouse bladder cancer model featuring basal-subtype gene expression and MLL3/MLL4 genetic disruption.
    Oncoscience. 2018;5.
    PubMed     Text format    


    PLoS One

  25. FERDOSI S, Ho TH, Castle EP, Stanton ML, et al
    Behavior of blood plasma glycan features in bladder cancer.
    PLoS One. 2018;13:e0201208.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  26. BANSAL A, Yang F, Xi T, Zhang Y, et al
    In vivo wireless photonic photodynamic therapy.
    Proc Natl Acad Sci U S A. 2018;115:1469-1474.
    PubMed     Text format     Abstract available


    Ther Adv Urol

  27. VAN VALENBERG FJP, Strauss-Ayali D, Agmon-Gerstein Y, Friedman A, et al
    Assessment of the efficacy of repeated instillations of mitomycin C mixed with a thermosensitive hydrogel in an orthotopic rat bladder cancer model.
    Ther Adv Urol. 2018;10:213-221.
    PubMed     Text format     Abstract available


    Urol Oncol

  28. NECCHI A, Lo Vullo S, Raggi D, Perrone F, et al
    Neoadjuvant sorafenib, gemcitabine, and cisplatin administration preceding cystectomy in patients with muscle-invasive urothelial bladder carcinoma: An open-label, single-arm, single-center, phase 2 study.
    Urol Oncol. 2018;36:8.
    PubMed     Text format     Abstract available

  29. THOMAS DE, Kaimakliotis HZ, Rice KR, Pereira JA, et al
    Commentary on "Prognostic effect of carcinoma in situ in muscle-invasive urothelial carcinoma patients receiving neoadjuvant chemotherapy."
    Urol Oncol. 2018;36:345.
    PubMed     Text format     Abstract available

  30. SOAVE A, Riethdorf S, Dahlem R, Minner S, et al
    Commentary on "Detection and oncological effect of circulating tumor cells in patients with variant urothelial carcinoma histology treated with radical cystectomy."
    Urol Oncol. 2018;36:347-348.
    PubMed     Text format     Abstract available


    Urologe A

  31. MIERNIK A
    [Nonmuscle invasive bladder cancer : Efficacy of electromotive drug administration].
    Urologe A. 2018 Jul 20. pii: 10.1007/s00120-018-0737.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: